Search

Your search keyword '"Watz, Henrik"' showing total 275 results

Search Constraints

Start Over You searched for: Author "Watz, Henrik" Remove constraint Author: "Watz, Henrik" Database Unpaywall Remove constraint Database: Unpaywall
275 results on '"Watz, Henrik"'

Search Results

1. Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET

4. Real-world walking cadence in people with COPD

6. Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET

7. Investigating the prognostic value of digital mobility outcomes in patients with chronic obstructive pulmonary disease: a systematic literature review and meta-analysis

8. Midregional pro atrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all- cause mortality in early COPD – Results from COSYCONET

10. Clinical factors linked to the type of respiratory medication in COPD: Results from COSYCONET

11. Proteasome function as a biomarker for severe COPD endotypes

12. Study design of a Phase 2 rollover trial of the novel cathepsin C inhibitor BI 1291583 in patients with bronchiectasis

16. Laboratory and free-living gait performance in adults with COPD and healthy controls

17. Clinical validation of real-world walking cadence in patients with COPD

20. Estimating the Health and Economic Impact of Improved Management in Prevalent Chronic Obstructive Pulmonary Disease Populations in England, Germany, Canada, and Japan: A Modelling Study

21. Laboratory and free-living gait performance in adults with COPD and healthy controls

24. CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPD

25. Patients’ acceptance of outcome and experience measurements during hospitalisation for COPD exacerbations: a cicero CRC - ELF online patient survey

26. A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis (Airleaf™)

27. Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma

29. Impact of Chewing Bags, E-Cigarettes, and Combustible Cigarettes on Arterial Stiffness and Small Airway Function in Healthy Students

30. Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort

31. Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality

33. Cardiovascular predictors of mortality and exacerbations in patients with COPD

34. Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?

36. Association of coronary artery calcification with clinical and physiological characteristics in patients with COPD: Results from COSYCONET

37. Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial

38. Qualitative Validation of COPD Evidenced Care Pathways in Japan, Canada, England, and Germany: Common Barriers to Optimal COPD Care

39. Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET

40. Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET

42. Longitudinal Impact of Sputum Inflammatory Phenotypes on Small Airway Dysfunction and Disease Outcomes in Asthma

43. Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement – the Mobilise-D study protocol

44. Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial

46. The arginine methyltransferase PRMT7 promotes extravasation of monocytes resulting in tissue injury in COPD

47. Monocyte migration and COPD pathogenesis are epigenetically regulated by PRMT7

48. Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study

50. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

Catalog

Books, media, physical & digital resources